RVC Medical IT has been acquired by NEXUS AG
Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.
RVC Medical IT is an innovative independent software vendor offering a comprehensive healthcare enterprise imaging software suite. RVC’s product range comprises specialized front-end client software for diagnostic workstations of radiology and all medical specialties outside radiology, complemented with a vendor neutral archive (VNA), RVC clinical repository, which can store all types of images (DICOM and Non-DICOM), documents, data and signals. Notable customers include Isala, UMC Utrecht, Tergooi, Kliniken des Landeskreises Lörrach and UZ Gent. The company is headquartered in Amersfoort, the Netherlands and employs more than 70 people. It has a market share of around 53% and a customer base of 41 hospitals.
Headquartered in Germany and with over 1,300 employees, NEXUS is a leading European healthcare software company and provider of hospital and diagnostic information systems.
Main Capital is a strategic investor with an exclusive focus on the software sector in the Benelux, DACH and Nordics regions. The firm has a long-term strategy of forming successful partnerships with management teams, with the aim of building larger software groups together. Main Capital has over US$1 billion in assets under management for investments in mature and growing software companies.
Oaklins’ team in the Netherlands advised the shareholders of RVC Medical IT.
Contáctese con el equipo de la transacción
Frederik van der Schoot
Oaklins Netherlands
Robbert Bon
Oaklins Netherlands
Transacciones relacionadas
Valmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Conozca másLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Conozca másCapsol has been acquired by Angus Capital
Capsol has been acquired by Angus Capital as part of its strategy to build a leading construction services group alongside other portfolio companies. This partnership marks a new phase of growth for Capsol, providing the platform, resources and strategic support needed to accelerate its development and expand its market presence.
Conozca más